The Decision-Making Blind Spot for Healthcare Leaders

by Who Decides, What Matters | Series Topic 1 | Jul 10, 2026

Key Insights

  • Many health system strategic initiatives underperform because they rely on historical data to predict future stakeholder behavior.
  • Traditional analytics explain what happened but cannot reliably forecast how physicians, patients, employers, or payers will respond to new market conditions.
  • In many specialty service lines, referring physicians—not patients—remain the primary drivers of where care is delivered, making referral behavior a critical strategic variable.
  • Behavioral decision intelligence has proven to enable organizations to test strategic assumptions before investing capital, reducing uncertainty and improving investment decisions.

Every year, U.S. health systems invest billions of dollars in strategic initiatives—from expanding service lines and ambulatory networks to launching digital care models and redesigning pricing strategies. These investments are typically supported by extensive planning, including claims analyses, market share reports, surveys, interviews, and focus groups.

Yet many strategic growth initiatives still fail to deliver their expected results (70%, according to McKinsey & Company). Referral leakage continues, out-of-network migration persists, and newly built capacity often falls short of projected demand. The problem is not simply execution. More often than not, organizations make forward-looking decisions using backward-looking data.

The Healthcare Decision Blind Spot

Traditional healthcare analytics are designed to explain yesterday's market—not predict tomorrow's. Claims data, utilization reports, and retrospective dashboards provide valuable operational insight, but they cannot reliably forecast how physicians, patients, employers, or payers will behave when presented with new choices, incentives, or competitive alternatives.

Likewise, conventional market research frequently measures what stakeholders say they might do rather than what they will choose when faced with real tradeoffs. As a result, healthcare leaders often allocate capital based on assumptions that have never been behaviorally tested using applied behavioral economics.

 

Referral Reality: The 80% Gatekeeper

One of the most common blind spots involves specialty care growth.

Many organizations focus expansion strategies on attracting patients through branding, digital engagement, and improvements in consumer experience. While these investments matter, behavioral decision modeling consistently demonstrates that, for many high-value specialty services, referring physicians control about 80% of referral volume, depending on the specialty and complexity of care.

When referral behavior is not incorporated into strategic planning, organizations risk investing heavily in patient acquisition while overlooking the behavioral factors that influence referral decisions. This is not simply a marketing challenge—it is a decision-making challenge.

Predicting Markets That Don't Yet Exist

Historical data cannot predict stakeholder behavior under conditions that have never existed, including:

  • New service line launches
  • Alternative care delivery models
  • Competitive market entrants
  • Changes in referral pathways
  • Pricing or site-of-care redesigns
  • New scheduling or access strategies

These decisions require understanding how stakeholders will respond—not simply how they responded in the past.

Replacing Assumptions with Behavioral Decision Intelligence

While uncertainty cannot be eliminated, it can be significantly reduced. By experimentally modeling real-world stakeholder behavior before implementation, healthcare organizations can:

  • Test strategic assumptions before investing capital.
  • Predict adoption and referral behavior.
  • Identify hidden sources of market friction.
  • Optimize service-line and operational design.
  • Improve capital allocation and investment returns.
  • Reduce the risk of costly strategic missteps.

Behavioral decision intelligence replaces assumptions with evidence. The result is greater confidence in strategic planning, improved capital allocation, and a reduced risk of costly investment mistakes. In future installments of the “Who Decides. What Matters.” series, we'll demonstrate how these behavioral models are developed, why they consistently predict real-world market behavior, and the results healthcare organizations have achieved by using them to guide high-stakes strategic and operational decisions.

Before launching your next strategic initiative, don't ask only, "What does the historical data tell us?"

Ask instead:

“Have we tested the behaviors that will determine whether this investment succeeds?”

 

From Market Health to Decision Intelligence: A New Imperative for Healthcare Leadership

Understanding physician and consumer preferences, service-line growth, vulnerability, and brand health is essential to better strategic decisions. Healthcare executives face a fundamental challenge: making forward-looking strategic decisions based on information that largely describes the past.

Market share, patient volumes, referral patterns, and financial performance remain essential management indicators. However, they cannot fully explain why physicians and consumers choose specific providers, how those preferences may change, or which investments will generate the greatest economic value.

For healthcare leaders, the critical question is not simply how a service line is performing but how healthy its competitive position is—and what leadership can do to strengthen it.

Market Health: Looking Beneath the Number

A service line can show strong historical growth while harboring significant competitive vulnerabilities. Conversely, a program with modest market share may have substantial untapped growth potential.

As discussed in MII's earlier article,  The Decision-making-Blind-spot-for-Healthcare-Providers, referring physicians direct approximately 80% of total volume through referrals across many high-value specialty services, depending on the specialty and the complexity of care.

Understanding physician preferences is therefore essential for simulating service-line growth and vulnerability.

Six dimensions influence physician choice:

  1. Brand: Institutional reputation, clinical credibility, and confidence.
  2. Medical Care: Clinical expertise, outcomes, quality, and care coordination.
  3. Access: Appointment availability, referral processes, and timely treatment.
  4. Price and Billing: Financial considerations, reimbursement, insurance acceptance, and administrative complexity.
  5. Communications and Services: Responsiveness, information exchange, and physician support.
  6. Technology: Advanced equipment, treatment capabilities, and clinical innovation.

Applied behavioral economics quantifies how physicians weigh these attributes when choosing providers, revealing competitive strengths and vulnerabilities that conventional market analysis is not designed to measure.

Translating Market Health into Economic Value

Understanding competitive strengths and weaknesses is only the first step. The greater opportunity is to translate physician and consumer preferences into two critical economic measures:

Growth Potential: How much additional volume and contribution margin could a service line capture by strengthening its competitive position?

Economic Vulnerability: How much existing volume and contribution margin could be lost as physician and consumer preferences shift, or competitors improve their offerings?

An orthopedic program may find that improving access creates greater economic opportunity than expanding capacity. An oncology program may identify referral growth through stronger brand positioning or clinical affiliations. A heart program may uncover substantial vulnerability tied to shifting physician and consumer preferences or competing cardiovascular capabilities.

These insights are difficult to derive from historical performance alone, yet they are central to applied behavioral economics.

From Market Intelligence to Decision Intelligence

Decision Intelligence goes beyond identifying the factors that drive physicians' and consumers' choices. It predicts how they will respond to alternative strategies and translates those responses into economic outcomes.

Discrete choice experiments provide an analytical foundation. By presenting physicians and consumers with realistic alternatives that vary in clinical capabilities, access, technology, brand, and other attributes, discrete choice experiments can be used to build an analytical foundation and quantify the relative influence of each factor on provider selection. The resulting behavioral models enable executives to simulate strategic alternatives well before committing resources.

Would improving orthopedic access generate more economic value than acquiring new surgical technology? Would an oncology affiliation drive greater referral growth than expanding clinical capabilities? Which cardiovascular investments would best protect existing referrals while attracting new ones?

Decision Intelligence connects predicted changes in physician choice to expected volume, contribution margin, investment requirements, and competitive risk.

The strategy that generates the greatest incremental volume may not deliver the greatest economic value when reimbursement, contribution margins, investment costs, and protection of existing business are considered.

A New Leadership Imperative

For healthcare CEOs, CFOs, and strategy executives, this marks a fundamental shift in strategic planning.  Capital is constrained. Competition is intensifying. Strategic decisions have substantial financial consequences.

Historical performance shows leaders where their service lines have been. Market Health reveals the behavioral and competitive forces shaping their future. Decision Intelligence provides the missing link by simulating how strategic alternatives will affect physician behavior, service-line performance, and economic value.

Together, they create a more forward-looking approach to service-line strategy—helping healthcare leaders determine not only where to grow and what to protect, but also which decisions will generate the greatest sustainable economic value.

_________________________________________________________________________________

Mi4Sight® is Market Innovations, Inc.’s behavioral economics modeling solution. Built on more than 20 years of experience and 135 healthcare studies, it helps leaders test innovative hypotheses, quantify likely behavior, and evaluate investments before committing capital. To learn more, visit Mi4sight | Market Innovations Inc.

.